skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration



这是Informa Pharma Intelligence 最新发布的Trialtrove®白皮书《中国临床试验格局》,Trialtrove 高级总监 Andy Benson 和Informa Pharma Intelligence亚太内容总监Dr. Annie Siu分析2016年至2020 年在中国开展的临床试验。结果显示,在中国开展的临床试验数量每年都在增长,我们还深入研究了在中国开展的临床试验的申办方、治疗领域还有类型,同时探索形成目前格局的动力与因素。欢迎大家收看! 



2017年,Informa Pharma Intelligence推出《中国能否成为临床开发的黑马》白皮书,深入分析了中国之前10年的临床试验整体格局。分析发现,中国启动的临床试验数目呈逐年上升趋势,这说明中国正在逐渐成为全球制药行业舞台上一支不可忽视的力量。



  • 中国在全球舞台上是否已经赶上制药行业的巨头?
  • 2016年至2020年期间在中国启动的试验
  • 中国临床试验的主要申办方
  • 各治疗领域的临床试验
  • 新冠疫情过后的未来发展

Trialtrove | 业内临床试验智库的黄金标准




隆重推出《中国临床试验格局》 作者: Annie Siu

Thank you for requesting a demo

We have received your request and we will get back to you soon.

Oops, there appears to be a problem

TC Existing Customer
Terms and Conditions
Additional Fields

Informa Privacy Policy    Informa Terms & Conditions

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: